116 related articles for article (PubMed ID: 9234301)
21. Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.
Costante G; Durante C; Francis Z; Schlumberger M; Filetti S
Nat Clin Pract Endocrinol Metab; 2009 Jan; 5(1):35-44. PubMed ID: 19079272
[TBL] [Abstract][Full Text] [Related]
22. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
23. Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer.
Kim HK; Bae WK; Choi YD; Shim HJ; Yoon JH; Kang HC
Thyroid; 2014 Mar; 24(3):599-603. PubMed ID: 23985043
[TBL] [Abstract][Full Text] [Related]
24. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D
Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900
[TBL] [Abstract][Full Text] [Related]
25. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin mRNA is produced in liver by two different splicing pathways.
Bracq S; Taboulet J; Machairas M; Lasmoles F; Houssin D; Moukhtar MS; Jullienne A
Mol Cell Endocrinol; 1997 Apr; 128(1-2):111-5. PubMed ID: 9140082
[TBL] [Abstract][Full Text] [Related]
27. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
28. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
Wion-Barbot N; Schuffenecker I; Niccoli P; Conte-Devolx B; Lecomte P; Houdent C; Bigorgne JC; Modigliani E
Ann Endocrinol (Paris); 1997; 58(4):302-8. PubMed ID: 9436479
[TBL] [Abstract][Full Text] [Related]
29. Medullary thyroid cancer with undetectable serum calcitonin.
Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
[TBL] [Abstract][Full Text] [Related]
30. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
[TBL] [Abstract][Full Text] [Related]
31. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
[TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
33. Interaction of bisphosphonates with calcitonin in monitoring medullary carcinoma of the thyroid.
Osborne ME; Brown RS; Hoskin PJ
Clin Oncol (R Coll Radiol); 2001; 13(5):370-1. PubMed ID: 11716232
[TBL] [Abstract][Full Text] [Related]
34. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
[TBL] [Abstract][Full Text] [Related]
35. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Machens A; Schneyer U; Holzhausen HJ; Dralle H
J Clin Endocrinol Metab; 2005 Apr; 90(4):2029-34. PubMed ID: 15634717
[TBL] [Abstract][Full Text] [Related]
36. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
37. "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature.
Leboeuf R; Langlois MF; Martin M; Ahnadi CE; Fink GD
J Clin Endocrinol Metab; 2006 Feb; 91(2):361-4. PubMed ID: 16278263
[TBL] [Abstract][Full Text] [Related]
38. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
39. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
40. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
